BLMH · Blum Holdings, Inc.
Market Cap
$5.05M
Shares
25.23M
BLMH metrics
60 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$0.16
Market cap
$5.05M
Price action
19 metricsPrice change (1W)
-10.0%
Price change (30D)
+12.5%
Price change (3M)
-41.9%
Price change (6M)
-37.9%
Price change (YTD)
-70.5%
Price change (1Y)
-73.5%
Trailing year
Price change (5Y)
—
52-week high
$0.73
52-week low
$0.15
Change from 52-week high
-75.3%
Change from 52-week low
+18.4%
Annualized volatility
202.2%
Beta
-0.5
RSI (14D)
48.5
Price vs SMA 50
-6.4%
Price vs SMA 200
-48.8%
Avg volume (3M)
3,724
Relative volume
0.1
Average dollar volume
$782
Company
3 metricsSector
Healthcare
Industry
Pharmaceutical Retailers
Shares outstanding
25.23M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
0.7×
reciprocal yield 146.8%
EV / EBITDA
0.6×
reciprocal yield 159.4%
EV / EBIT
0.7×
reciprocal yield 150.6%
P / sales
0.3×
reciprocal yield 299.9%
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
234.3%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
1.0×
reciprocal yield 97.4%
EV / revenue historical average (5Y)
1.0×
reciprocal yield 97.4%
EV / EBIT historical average (3Y)
1.6×
reciprocal yield 61.5%
EV / EBIT historical average (5Y)
1.6×
reciprocal yield 61.5%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
—
Profitability
9 metricsGross margin
48.2%
Operating margin
102.6%
Trailing 12 months
Net margin
78.1%
Gross profit (TTM)
$6.57M
Operating profit (TTM)
$13.98M
Net income (TTM)
$10.64M
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
12.7%
Growth
11 metricsRevenue growth YoY
+11.1%
Year over year
Net income growth YoY
—
Revenue (TTM)
$13.62M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+11.5%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
—
Return on assets
23.6%
Debt / equity
—
Current ratio
0.1
EBITDA (TTM)
$14.79M
Free cash flow (TTM)
—
Quick ratio
0.0
Interest coverage
—
Net debt / EBITDA
0.3
Return on invested capital
—
Trailing 12 months
Net cash
−$4.74M
Latest balance sheet
Cash & equivalents
$388,000
Total assets
$45.08M
Total debt
$5.12M
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$1.75M
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
$12.53M
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
3 metrics13F filers
2
13F filer change QoQ
+1
Institutional ownership
0.0%
Short interest
3 metricsShort interest
0.0%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
28 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—